Fiche centre
Erasmus MC
Rotterdam — Netherlands
Essais liés3clinical trials
VilleRotterdamlocalisation
PaysNetherlandslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT05683860
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| WVE-004 10 mg Q12W | Sclérose latérale amyotrophique | Phase 1/2 | NCT05683860 | Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD) | TERMINATED |
| K+ in CKD — Potassium Supplementation in CKD | Hypertension | Non applicable | NCT03253172 | K+ in CKD — Potassium Supplementation in CKD | ACTIVE_NOT_RECRUITING |
| Acoramidis | Alzheimer | Phase 3 | NCT06563895 | Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant | RECRUITING |